ComplianceOnline

Muni Pay-to-Play Rules – Stricter than Before?

  • Date: March 18, 2010
  • Source: Admin
Webinar All Access Pass Subscription Abstract:

Released in December 2009, the ‘Pay-to-Play’ rule of SEC was intended “to ensure that the high standards and integrity of the municipal securities industry are maintained, to prevent fraudulent and manipulative acts and practices, to promote just and equitable principles of trade, to perfect a free and open market and to protect investors and the public interest by: (i) prohibiting brokers, dealers and municipal securities dealers from engaging in municipal securities business with issuers if certain political contributions have been made to officials of such issuers; and (ii) requiring brokers, dealers and municipal securities dealers to disclose certain political contributions, as well as other information, to allow public scrutiny of political contributions and the municipal securities business of a broker, dealer or municipal securities dealer.”

In an announcement made on March 18, 2010, SEC clarifies that the municipal securities rule of pay-to-play does not only apply to just a firm's employees, rather affiliated financial firms also come in its purview.  

According to the pay-to-play rule, MSRB Rule G-37, firms should restrict themselves from underwriting municipal bonds for an issuer for two years after a municipal finance professional (MFP) involved with that firm makes a campaign contribution to an elected official of that municipality.

In fact, as per the rule, an investment adviser who makes a political contribution to an elected official in a position to influence the selection of the adviser can be barred for two years from providing advisory services for compensation, either directly or through a fund.

However, through its Report of Investigation, SEC clears that any executive supervising the activities of a broker, municipal securities or dealers will not be exempted from MSRB's pay-to-play rule just because he or she may be outside the firm's corporate governance structure.

Source:

http://www.sec.gov/news/press/2010/2010-42.htm

http://www.sec.gov/news/press/2009/2009-168.htm




 

Bookmark and Share

Trending Compliance Trainings

Trial Master File and Clinical Data Management Regulated by FDA
By - Carolyn Troiano
On Demand Access Anytime
Good Documentation Practice and Record Keeping Regulations (FDA & EMA)
By - Dr. Afsaneh Motamed Khorasani
On Demand Access Anytime
GAMP Data Integrity 21 CFR Part 11 Training Course
By - Kelly Thomas
On Demand Access Anytime
NEW Reclamation Process - Fed Gov't Payments
By - Donna K Olheiser
Live February 11, 2026
Understanding and Preparing for FDA Pharmaceutical Inspections
By - Michael Ferrante
On Demand Access Anytime
How to conduct an effective BSA Audit
By - Justin Muscolino
On Demand Access Anytime
Installation and Qualification of the Packaging Lines
By - John E Lincoln
On Demand Access Anytime
Best Sellers
You Recently Viewed
    Loading